Recent trading data for CLOV shows higher-than-average volume, reflecting increased retail interest. Technical charts indicate a possible breakout above the $1.50 resistance if positive earnings guidance continues in Q3 At first glance it's a bit worrying to see that Clover Health Investments actually boosted its cash burn by 33%, year on year. Also concerning, operating revenue was actually down by 20% in that time. Taken together, we think these growth metrics are a little worrying. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years . We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025 . In this article, we are going to take a look at where Clover Health Investments, Corp. (NASDAQ:CLOV) stands against the other stocks that are skyrocketing now. CLOV stock forecast is buoyed by policy shifts in Medicare Advantage markets. Analysts project low double-digit percentage growth in memberships, which could influence share price toward $1.70 by year-end if margins improve.